Business UpdateApr 27, 2026, 11:51 AM
TVGN Tevogen.AI's PredicTcell™ Nears Completion, Commercial Readiness
AI Summary
Tevogen Bio Holdings Inc. announced significant progress in its artificial intelligence initiative, Tevogen.AI, with its PredicTcell™ training algorithm nearing completion. The proprietary machine learning model, designed to identify immunologically active peptides, has been trained on a large dataset, expanding to over 180 parameters and achieving an approximate 10% improvement in precision. The company is also evaluating potential co-development partnerships and has developed an internal application for the model, laying the groundwork for a future customer-facing platform.
Key Highlights
- Tevogen.AI's PredicTcell™ training algorithm is nearing completion.
- The model has been trained on one of the industry’s largest curated peptide datasets.
- Feature expansion for PredicTcell™ now exceeds 180 parameters.
- Precision of the PredicTcell™ model has improved by approximately 10%.
- Tevogen is evaluating potential co-development partnerships for the platform.
- An initial internal application and portal for PredicTcell™ has been developed.
Price Impact
More from TVGN